Woodline Partners »

Keros Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $36M 776k 45.70
2024-03-31 $50M 762k 66.20
2023-09-30 $23M 718k 31.88
2023-06-30 $11M 280k 40.18
2023-03-31 $8.5M 198k 42.70
2022-12-31 $9.4M 197k 48.02
2022-09-30 $13M 343k 37.62
2022-03-31 $14M 257k 54.38
2021-12-31 $4.5M 76k 58.51
2021-09-30 $7.4M 188k 39.56